Results 191 to 200 of about 1,057,002 (233)
Some of the next articles are maybe not open access.
Minor Histocompatibility Antigens in GVL
2000In syngeneic bone marrow transplantation (BMT) and in recipients of autologous BMT, relapse rates are high. No MHC or minor histocompatibility antigen (mHag) disparities exist and thus no alloreactivities can be induced. This is clearly different in allogeneic BMT, where the relapse rates are significantly lower and a relationship is seen between the ...
Mutis, Tuna, Goulmy, Els
+7 more sources
Tolerance to minor histocompatibility antigens
Immunology Letters, 1988A neonatal tolerance model employing fully allogeneic lymphoid cells as tolerogen was used in an investigation of tolerance to self and donor minor histocompatibility antigens (miHA). Tolerance was assessed by skin grafting and subsequently by the generation of cytotoxic T lymphocytes. Two strain combinations were investigated. In the first, BALB/c-B10,
L S, Rayfield, L, Brent, K, Samuel
openaire +2 more sources
Minor histocompatibility antigens
Immunology Letters, 1991Immune responses against foreign tissue or organs can be directed against alloantigenic differences between donor and host encoded by genes of the major histocompatibility complex (MHC; HLA in man and H-2 in mouse). However, when MHC antigens are matched, as in HLA-identical siblings, or between different mouse strains sharing the same H-2 haplotype ...
openaire +4 more sources
Minor Histocompatibility Antigens and Marrow Transplantation
New England Journal of Medicine, 1996Acute graft-versus-host disease (GVHD) and graft rejection are the principal obstacles to successful allogeneic bone marrow transplantation.
N A, Kernan, B, Dupont
openaire +2 more sources
Major vs minor histocompatibility antigens
Blood, 2017In this issue of Blood, Martin et al found that the number of minor histocompatibility antigen mismatches doubles in unrelated vs sibling HLA-matched transplants, but has less impact on graft-versus-host disease (GVHD) than mismatching at HLA-DP ...
Denis Claude Roy, Claude Perreault
openaire +2 more sources
Immunodominant Minor Histocompatibility Antigens: The Major Ones
Trends in Immunology, 1998Abstract Minor histocompatibility antigens (MiHAs) are extremely numerous—possibly up to 720 in mice—and have been regarded as an `immunogenetic nightmare' in transplantation. Here, Claude Perreault, Denis Roy and Claudette Fortin summarize evidence showing that most anti-MiHA T-cell responses are oligoclonal, being restricted to several dominant ...
Claude Perreault, Claudette Fortin
exaly +3 more sources
Minor histocompatibility antigens – big in tumour therapy
Trends in Immunology, 2004Technical advances combined with the deciphering of the human genome have facilitated the identification of the molecular nature of human minor histocompatibility (H) antigens. To date, it is believed that minor H antigens result from just any polymorphic protein, regardless of their functional properties.
Spierings, E. +2 more
openaire +3 more sources
Presentation and recognition of major and minor histocompatibility antigens
Transplant Immunology, 1994The structural basis of allorecognition is heterogeneous. For minor histocompatibility antigen-specific T cells and for a minority of anti-MHC T cells (indirect allorecognition), the allogeneic molecule acts as any other protein, and is processed and presented as a peptide in the context of self MHC.
A N, Warrens, G, Lombardi, R I, Lechler
openaire +2 more sources
Much ado about minor histocompatibility antigens
Immunology Today, 1998Abstract Current knowledge of histocompatibility (H) loci located outside of the major histocompatibility complex - i.e. those encoding the so-called minor H antigens - was surveyed at a recent meeting ∗ ∗The 1st International Symposium on Minor Histocompatibility Antigens was held at Bar Harbor, ME, USA, on 14–17 September 1997..
Simpson, E, Roopenian, D, Goulmy, E
openaire +3 more sources
Molecular Typing Methods for Minor Histocompatibility Antigens
2007Minor histocompatibility (H) antigens crucially affect the outcome of human leukocyte antigen-matched allogeneic stem cell transplantation. The number of molecularly identified minor H antigens is rapidly increasing. In parallel, clinical implementation of minor H antigens for immunotherapy has gained significant interest.
Eric, Spierings, Els, Goulmy
openaire +2 more sources

